News | News By Subject | News by Disease News By Date | Search News

Infection/Antibiotics News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Warp Drive Bio Hands Over Antibiotics Program to Sanofi (SNY)     11/30/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials     10/25/2016
A Closer Look at the Pipelines Pfizer (PFE) Inherited From Recent Acquisitions     10/5/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072     8/15/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales     7/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set     7/22/2016
FDA Spurns Novartis AG (NVS)'s Copy of Amgen (AMGN) Blockbuster Neulasta     7/19/2016
FDA Advisors Backs Approval for Merck & Co. (MRK)'s Infectious Diarrhea Drug     6/10/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy     6/8/2016
FDA Warns Against Off-Label Use of Johnson & Johnson (JNJ)'s Nizoral Tablets to Treat Skin And Nail Infections, Linked to Patient Death     5/20/2016
TetraPhase (TTPH) Drops After the FDA Requests More Data for Eravacycline NDA Submission     5/13/2016
More Bad News for Chimerix (CMRX) as Brincidofovir Fails Another Late Stage Study     5/9/2016
Basilea (BSLN.SW) Wins $100 Million Contract to Fund Phase III Ceftobiprole Program     4/20/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge     4/14/2016

News from Around the Web
New Test Can ID Dangerous Bacteria With Resistance To Last-Resort Antibiotic, European Society of Clinical Microbiology and Infectious Diseases Reveals     4/24/2017
Can Maple Syrup Extract Make Antibiotics Kill Bacteria Easily? McGill University Study Reveals     4/5/2017
Common Antibiotic May Help To Prevent Or Treat PTSD, University of Zurich Study Reveals     4/4/2017
Who Is On The WHO's New Most Dangerous Superbugs List     2/28/2017
Woman Dies Of A Superbug Resistant To Every Antibiotic In The U.S., CDC Study     1/13/2017
From Click Chemistry To Antibiotic Spider Silk, University of Nottingham Study     1/9/2017
Portable Antibiotic Resistance Detector Developed, UCLA Study     12/27/2016
New Tool May Help Combat Antibiotic Resistance, University of Sheffield Study     11/1/2016
Scientists Are Freaking Out Over This 25-Year-Old's Solution To Superbugs, University Of Montreal Study     9/28/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
Saving Antibiotics So That Antibiotics Can Save Lives     9/16/2016
Kids With Exposure To Antibiotics Linked To Allergies Later In Life, Utrecht University Study     9/6/2016
Rapid Bacterial Infection Test Reduces Antibiotic Use, University of Oxford Study     8/3/2016
A Potential Lifesaver Lies Unrecognized In The Human Body, University of Tubingen Study     7/28/2016
Infections, Antibiotic Use Linked To Manic Episodes In People With Serious Mental Illness, Johns Hopkins University School of Medicine Study     7/21/2016

Press Releases
Theravance Biopharma (TBPH) Release: New Data For VIBATIV (Telavancin) Reported In Several Presentations At ECCMID 2017     4/25/2017
Eight Data Presentations At ECCMID Showcase The Broad Applicability Of SCYNEXIS, Inc. (SCYX)’ Lead Anti-Infective Candidate SCY-078     4/25/2017
Paratek Pharma (PRTK) Release: Omadacycline Concentrations Exceed Tigecycline Levels In Lungs And Epithelial Lining Fluid According To Pharmacokinetic/Pharmacodynamic (PK/PD) Data     4/25/2017
AmpliPhi Bio (APHB) Announces Presentation Of Personalized Bacteriophage Therapy Case Study For Life-Threatening Antibiotic-Resistant Infection At Scientific Conference     4/25/2017
Zai Lab Acquires China Rights To Novel Antibiotic From Paratek Pharma (PRTK)     4/25/2017
New Microbiology Data From Paratek Pharma (PRTK) Show Omadacycline Effective Against Most Common Skin Infections And Pathogens, Including MRSA     4/24/2017
Basilea (BSLN.SW) Announces Agreement With FDA On Special Protocol Assessments For Antibiotic Ceftobiprole Phase III Clinical Studies In Bloodstream And Skin Infections     4/21/2017
Motif BioSciences, Inc. Announces Positive Results For Iclaprim, In The REVIVE-1 Phase III Study     4/18/2017
Novan Reports Positive Topline Results With SB208 In Phase II Trial     4/12/2017
Rebiotix Reports Positive Top Line Data From Open-Label Phase II Trial Of RBX2660 In Recurrent Clostridium Difficile     4/11/2017
Appili Receives Funding From The Government Of Canada To Support Development Of New Antibiotic To Treat Gram-Negative Infections     4/11/2017
Avivagen Reports Positive Proof Of Concept In Preventing C. Difficile Infection     4/10/2017
Vomaris' Technology Impacts Biofilm-induced Antibiotic Resistance     4/10/2017
Tru-D SmartUVC Helps To Reduce C. Diff Infections At Chesapeake Regional Healthcare     4/7/2017
Paratek Pharma (PRTK) Rockets as New Antibiotic Drug Passes Phase III Test     4/4/2017

//-->